Streetbeat News

Stock Prices

SKX

Skechers USA (NYSE:SKX) has seen a 25.41% increase in short interest since its last report, with 2.53 million shares sold short, representing 2.27% of its float. The current short interest suggests a bearish market sentiment towards SKX, although it's lower than the peer group average of 8.59%. The article highlights the importance of tracking short interest as an indicator of market sentiment.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 4:45 pm

MAR

Marriott Intl's (NYSE:MAR) short interest has increased by 8.3%, with 5.88 million shares sold short, representing 2.61% of its float. It would take about 3.9 days to cover these short positions. This rise in short interest can indicate a bearish market sentiment towards MAR, although it has less short interest compared to its peers, with an average of 6.09% in the peer group.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 4:45 pm

PVH

PVH Corp's (NYSE:PVH) short interest has decreased by 11.07%, with 2.04 million shares sold short, representing 4.5% of its float. This decrease in short interest could indicate a more bullish sentiment towards PVH among traders. Compared to its peers, PVH has a lower short interest percentage of float, with the average being 8.50%. Short interest is a key indicator of market sentiment, and a decrease suggests that investors may be becoming more optimistic about the company's stock.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 4:45 pm

BNO

USO

Oil prices have declined following the Energy Information Administration's (EIA) revision of its 2024 world demand growth forecast downwards.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 4:45 pm

MPC

Marathon Petroleum's stock is trading lower due to a decrease in oil prices.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 4:44 pm

PANW

Palo Alto Networks' stock is trading higher following the announcement of an expanded partnership with Google Cloud. This development is expected to enhance the company's cloud security offerings and potentially increase its market share in the cybersecurity sector.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 4:44 pm

TLRY

Tilray Brands Inc (NASDAQ:TLRY) shares dropped significantly after the company reported third-quarter revenue of $188.34 million, missing the consensus estimate of $198.5 million, and announced it no longer expects to generate positive adjusted free cash flow for FY 2024. Despite a 30% year-over-year increase in revenue and growth in various business segments, the revised financial outlook and missed earnings estimates have negatively impacted investor sentiment.

Portfolio Pulse from Adam Eckert

April 09, 2024 | 4:38 pm

RKT

'Transforming The Home Buying Process': Rocket Mortgage, a part of Rocket Companies Inc. (NYSE:RKT), has launched Rocket Logic, an AI-driven platform designed to simplify and speed up the home ownership process. The platform uses over 10 petabytes of data and 50 million annual call transcripts to enhance mortgage efficiency through deep learning and generative AI, significantly reducing the time for loan closures and improving the accuracy of mortgage eligibility determinations.

Portfolio Pulse from Nabaparna Bhattacharya

April 09, 2024 | 4:37 pm

MTEM

Molecular Templates, Inc (NASDAQ:MTEM) shares experienced volatility after presenting positive interim data from its MT-6402 Phase I study in patients with PD-L1+ solid tumors. The data showed MT-6402's unique action and good tolerance, with no severe adverse events. CEO Eric Poma highlighted the drug's potential in treating checkpoint-experienced head and neck cancer patients. The stock saw heavy trading, with over 1.47 million shares traded, significantly above its 100-day average.

Portfolio Pulse from Erica Kollmann

April 09, 2024 | 4:37 pm

VVOS

Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares dropped after filing a prospectus for the resale of up to 1.73 million shares by selling shareholders. The company could receive $8.4 million if all warrants are exercised. Vivos also announced Medicare reimbursement approval for its CARE oral medical devices and reported Q4 losses of $3.05 per share, missing estimates by 59.69%, with sales of $3.248 million also missing estimates.

Portfolio Pulse from Erica Kollmann

April 09, 2024 | 4:36 pm